A practical reference on lyophilisation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-05-23 and is reviewed periodically as new material appears.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Studied for metabolic indications |
| Receptor activity | GIP, GLP-1, and glucagon | Single molecule, three targets |
| Development status | Investigational | Not an approved therapy |
| Common synonym | LY3437943 | Development designation |
| Administration route | Subcutaneous injection | As used in clinical studies |
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
=== Awards === The Orange Box won a number of awards for its overall high standard and use of technology. The compilation won "Computer Game of the Year" at the Academy of Interactive Arts & Sciences' 11th Annual Interactive Achievement Awards; it also received nominations in the "Overall Game of the Year", "Action Game of the Year", and "Outstanding Innovation in Gaming" categories. The Orange Box won the "Breakthrough Technology Award" and the "Best PC Game Award" at the 2007 Spike Video Game Awards, and was additionally nominated in the "Game of the Year", "Best Shooter", "Best Xbox 360 Game", and "Best Multiplayer Game" categories. It was also named the second-best video game of 2007 by Time Magazine, while the PlayStation 3 version was nominated in the category of Action and Adventure at the BAFTA Video Games Awards. Valve also received developer awards for their work on The Orange Box. The Orange Box received 17 Game of the Year awards and over 100 awards in total. The Orange Box was placed as the 22nd most influential video game in history by the Guinness World Records Gamer's Edition, 2009. Portal won "Outstanding Achievement in Game Design", "Outstanding Achievement in Gameplay Engineering", and "Outstanding Character Performance" for Ellen McLain's vocal portrayal of GLaDOS at the 11th Annual Interactive Achievement Awards. The game won 76 awards, including 37 Game of the Year awards, and was recognized for innovative design and game mechanics. The dark humor of Portal and the ending music track "Still Alive" were also singled out for awards.
== External links == "Ghrelin Receptor". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2015-07-11. Retrieved 2007-10-25. growth+hormone+secretagogue+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Ghrelin Archived 2008-05-12 at the Wayback Machine at Colorado State University This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This is a list of monarchs of the Netherlands (Dutch: Koningen der Nederlanden). The list includes the pre-monarchical stadtholders of the House of Orange-Nassau (1572–1795), the hiatus of the French puppet monarchy (1806–1810), and the return of the House of Orange-Nassau as monarchs (1813–present). The list starts in 1572, when the Estates of Holland independently reinstated William the Silent as their stadtholder. He had previously been dismissed by the Spanish King Philip II, due to his leading role in the Dutch Revolt, and his reinstatement marked a pivotal step toward the emergence of an independent state under the political and military leadership of the House of Orange-Nassau. He established the royal status of this dynasty by inheriting the sovereign Principality of Orange, adding to his existing title as Count of Nassau the title 'Prince of Orange' —a lineage and a colour with which all subsequent stadtholders and, to this day, all Dutch monarchs are exclusively associated. For this reason, he is better known in the Netherlands as William of Orange. As stadtholder he is known as William I, as later heirs (both stadtholders and monarchs) would bear his name in remembrance of his stature. In the national anthem the "Wilhelmus", he features as Wilhelmus/Willem of Nassau. Written around 1570 in his honor, the song explicitly designated him as ‘Genaedigen Forsten’ (“Gracious Sovereign”) and Patris Patriae (“Father of the Nation”).
=== Benefits of GSK-3β inhibitors === In diabetes, GSK-3β inhibitors increase insulin sensitivity, glycogen synthesis, and glucose metabolism in skeletal muscles, and reduce obesity by affecting the adipogenesis process. GSK-3β is also over expressed in several types of cancers, like colorectal, ovarian, and prostate cancer. GSK-3β inhibitors also aid in the treatment of Alzheimer's disease, stroke, and mood disorders, including bipolar disorder. In vitro studies have shown the beneficial effects of GSK-3 inhibitors in lung cancer, ovarian cancer and neuroblastoma.
Sources: en.wikipedia.org
Portugal is located in the Mediterranean basin, a biodiversity hotspot. It is home to six terrestrial ecoregions: Azores temperate mixed forests, Cantabrian mixed forests, Madeira evergreen forests, Iberian sclerophyllous and semi-deciduous forests, Northwest Iberian montane forests, and Southwest Iberian Mediterranean sclerophyllous and mixed forests. Almost a quarter of its land area is included in the Natura 2000 network. Native species such as holm oak, cork oak, stone pine, and maritime pine make up 72% of the total forested area of continental Portugal. Portugal and Spain have a higher proportion of endemic freshwater fish species than elsewhere in Europe, at 73%. Among Portugal's protected areas are the Southwest Alentejo and Vicentine Coast Natural Park, one of Europe's last remaining stretches of wild coastline, and Montesinho Natural Park, which preserves one of the few intact Mediterranean mountain landscapes. Geographical and climatic conditions facilitate the spread of invasive plant species. Over one-fourth of extant plant species in continental Portugal are exotic. Portugal has one of the highest numbers of threatened animal and plant species in Europe. Portugal is an important stopover for migratory birds, as its wetlands serve as key wintering and stopover sites for many waders due to their location on the East Atlantic Flyway.
By the turn of the 20th century, the science of forensics had become largely established in the sphere of criminal investigation. Scientific and surgical investigation was widely employed by the Metropolitan Police during their pursuit of the mysterious Jack the Ripper, who had killed a number of women in the 1880s. This case is a watershed in the application of forensic science. Large teams of policemen conducted house-to-house inquiries throughout Whitechapel. Forensic material was collected and examined. Suspects were identified, traced and either examined more closely or eliminated from the inquiry. Police work follows the same pattern today. Over 2000 people were interviewed, "upwards of 300" people were investigated, and 80 people were detained. The investigation was initially conducted by the Criminal Investigation Department (CID), headed by Detective Inspector Edmund Reid. Later, Detective Inspectors Frederick Abberline, Henry Moore, and Walter Andrews were sent from Central Office at Scotland Yard to assist. Initially, butchers, surgeons and physicians were suspected because of the manner of the mutilations. The alibis of local butchers and slaughterers were investigated, with the result that they were eliminated from the inquiry. Some contemporary figures thought the pattern of the murders indicated that the culprit was a butcher or cattle drover on one of the cattle boats that plied between London and mainland Europe. Whitechapel was close to the London Docks, and usually such boats docked on Thursday or Friday and departed on Saturday or Sunday.
Developed over the course of five years, Entropy: Zero 2 was released in August 2022 to positive reviews on Steam, and went on to win Mod DB's 2022 "Mod of the Year" award in the "Players Choice" category. Flipside - A side-scrolling platform game that allows the player to "flip" the game world around to its backside, altering the means a player can traverse a level. Half-Life 2: Overcharged - A single-player mod for Half-Life 2 that adds new enemies and locations as well as cut content, extending the base game. Originally released in 2022, the mod gained notoriety in 2024 due to the mod developers blacklisting content creators that criticized the mod by targeting their Steam IDs and crashing their game. This led to the mod being review bombed on Mod DB. Jurassic Life - A modification based on the first Jurassic Park film. The game acts as a side story to the movie where the player takes the role of the park's game warden, Robert Muldoon. Korsakovia - A single-player mod for Half-Life 2. It was developed by The Chinese Room and released September 19, 2009. In Korsakovia, the player travels through the delusions of Christopher, a man suffering from Korsakoff's Syndrome. The player hears the voices of Christopher and a doctor as they try to work out what is wrong with Christopher. Minerva - An episodic single-player mod based in the Half-Life 2 universe, using storytelling inspired by classic games such as Marathon and System Shock. Operation Black Mesa - An upcoming remake of the Half-Life expansion Opposing Force developed by Tripmine Studio.
== See also == Comparative endocrinology Endocrine disease Hormone Hormone replacement therapy Neuroendocrinology Pediatric endocrinology Reproductive endocrinology and infertility Wildlife endocrinology List of instruments used in endocrinology
Major Grahame Wilson , also known as "The Phantom Major", is a retired Rhodesian Army officer who served as second-in-command of the Rhodesian Special Air Service (SAS). He is the most decorated member of the Rhodesian Army.
Sources: en.wikipedia.org
Fishmeal and oil from residues instead of whole fish have a different composition with more ash and less protein, which may limit its potential use for aquaculture. As the salmon farming industry expands, it requires more wild forage fish for feed, at a time when seventy-five percent of the world's monitored fisheries are already near to or have exceeded their maximum sustainable yield. The industrial-scale extraction of wild forage fish for salmon farming then impacts the survivability of the wild predator fish who rely on them for food. An important step in reducing the impact of aquaculture on wild fish is shifting carnivorous species to plant-based feeds. Salmon feeds, for example, have gone from containing only fishmeal and oil to containing 40 percent plant protein. The USDA has also experimented with using grain-based feeds for farmed trout. When properly formulated (and often mixed with fishmeal or oil), plant-based feeds can provide proper nutrition and similar growth rates in carnivorous farmed fish. Another impact aquaculture production can have on wild fish is the risk of fish escaping from coastal pens, where they can interbreed with their wild counterparts, diluting wild genetic stocks. Escaped fish can become invasive, out-competing native species.
== Toxicity == BmK venom induces a transient phase of contraction followed by a slow progressive flaccid paralysis in insect larvae. However, since it requires a high dosage to be effective, its toxicity is weak, both in insects and mammals.
For his contributions to the development and progress of Malaysia, Mahathir was honoured by his successor, Abdullah Badawi, with the title Bapa Pemodenan Malaysia (Father of Malaysia's Modernisation) after stepping down from office. The following year, Barisan Nasional leaders and members paid tribute to Mahathir during a dinner in Kuala Lumpur, acknowledging his remarkable contributions to the coalition and the nation.
== History == The detection of nitrates and nitrites for GSR has been around since the early 1900s. The first recorded use of paraffin wax as a lifting medium was done by Dr. Iturrioz in 1914 and was popularized in 1933 by Teodoro Gonzalez of the Mexico City Police Laboratory. The aptly named paraffin test is also referred to as the diphenylamine test, dermal nitrate test and the Gonzalez test. This test consisted of coating a suspect's hands with paraffin wax, allowing it to solidify and peeling it away before adding a diphenylamine/sulfuric acid reagent. The presence of dark blue spots is said to indicate a positive result. This is no longer used in casework due to the high number of false positives caused by the commonality of nitrates and nitrites in a variety of mundane products such as fertilisers. In 1971 John Boehm presented some micrographs of gunshot residue particles found during the examination of bullet entrance holes using a scanning electron microscope. If the scanning electron microscope is equipped with an energy-dispersive X-ray spectroscopy detector, the chemical elements present in such particles, mainly lead, antimony and barium, can be identified. In 1979 Wolten et al. proposed a classification of gunshot residue based on composition, morphology, and size. Four compositions were considered characteristic:
glycolipid Any of a subclass of lipids consisting of a central polar molecule (most commonly glycerol or sphingosine) which is covalently attached to one or more monosaccharides or oligosaccharides via glycosidic bonds, as well as to one or more long, non-polar fatty acid chains. Glycolipids are one of three major types of membrane lipid comprising all biological membranes, along with phospholipids and cholesterol.
Sources: en.wikipedia.org
It is described as a single molecule that acts at three receptors: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This triple activity distinguishes it from agents that target one or two of these pathways.
It is characterized in the literature as an investigational agent under clinical study. Approval status depends on jurisdiction, and readers should check current regulatory information rather than assume availability.
The combination is intended to pair appetite-related and glucose-related effects with mechanisms that increase energy expenditure. Whether the combined profile offers advantages over simpler agonists is the subject of ongoing research.
Retatrutide is an investigational synthetic peptide that activates three metabolic receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes. It has not been approved for clinical use.